If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Director Shareholding

13 Oct 2020 07:00

RNS Number : 8508B
Quixant PLC
13 October 2020
 

 

13 October 2020

Quixant plc

("Quixant" or the "Company" or the "Group")

 

Director Shareholding

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, announces that it was informed on 12 October 2020 that Jon Jayal, Chief Executive Officer purchased 4,191 ordinary shares of 0.1p each ("Ordinary Shares") at a price of 119.00 pence per Ordinary Share and 4,156 Ordinary Shares at a price of 120.00 pence per Ordinary Share (the "Purchases").

Following the Purchases, Jon Jayal is beneficially interested in 383,547 Ordinary Shares, representing approximately 0.58 per cent. of the Company's issued share capital.

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail on the transactions.

 

Quixant plc

Tel: +44 (0)1223 892 696

Jon Jayal, Chief Executive Officer

Andrew Jarvis, Interim Chief Financial Officer

Nominated Adviser and Broker:

finnCap Ltd

Tel: +44(0)20 7220 0500

Matt Goode / Simon Hicks (Corporate Finance)

Alice Lane (Corporate Broking)

Financial PR:

Tel: +44 (0) 20 3405 0205

Alma PR

John Coles / Susie Hudson / David Ison / Kieran Breheny

 

About Quixant

 

Quixant, founded in 2005, was established as a designer and manufacturer of highly optimised computing and display solutions for the global gaming industry. Through the acquisition of Densitron Technologies plc in 2015, the Company diversified into other markets and has a focused technology offering for the broadcast sector, leveraging the business' extensive sector knowledge across many industries.

 

The Company is headquartered in Cambridge in the UK, with a global customer base and offices in North America, Europe and Asia. The Taiwanese operation is responsible for design, procurement and manufacturing of the Company's products. Quixant owns all its IP, some of which is protected by patents and design rights.

 

In-depth information on the Company's products, markets, activities and history can be found on the corporate website at www.quixant.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Jon Jayal

2.

Reason for the notification

a)

Position/status:

CEO

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Quixant plc

 

b)

LEI:

2138003VERSWQP561X71

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1p

 

GB00B99PCP71

b)

Nature of the transaction:

Purchase of ordinary shares of 0.1p

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

119.0p

4,191

120.0p

4,156

d)

Aggregated information:

· Aggregated volume:

· Price:

Purchase of 8,347 ordinary shares at an average price of 119.5p per ordinary share

e)

Date of the transaction:

12 October 2020

 

f)

Place of the transaction:

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBDFBDDQKD
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.